On May 17, Illumina's official WeChat account announced that the company had reached a strategic cooperation with Sinopharm (Shanghai) Medical Device Supply Chain Co., Ltd. ("Sinopharm Medical Device Shanghai"), a subsidiary of China Medical Device Corporation under China National Pharmaceutical Group. In the future, Sinopharm Medical Device Shanghai will serve as Illumina's platform provider in the research field in mainland China, and based on logistics platform cooperation, accelerate the localization process of innovative products.
